Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1978;57:366-372

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mangiardi, L. M.
Right arrow Articles by Shabetai, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mangiardi, L. M.
Right arrow Articles by Shabetai, R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*VERAPAMIL HYDROCHLORIDE

Circulation, Vol 57, 366-372, Copyright © 1978 by American Heart Association


ARTICLES

Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations

LM Mangiardi, RJ Hariman, RG McAllister Jr, V Bhargava, B Surawicz and R Shabetai

Verapamil was administered intravenously to 30 open-chest dogs and the electrophysiologic and hemodynamic effects of the drug were correlated with the corresponding plasma concentrations. At concentrations below 152 ng/ml, verapamil prolonged the A-H interval, abolished ventriculoatrial conduction, but did not significantly change sinus rate, cardiac output, left ventricular dp/dt, of systemic vascular resistance. Concentrations above 200 ng/ml were associated with slowing of the sinus rat, high degree atrioventricular block during atrial pacing, 24% decrease in mean aortic pressure, and decreased cardiac output and left ventricular dp/dt. Sinus arrest, high degree atrioventicular block during sinus rhythm, decreased systemic vascular resistance and increased left ventricular end-diastolic pressure occurred when plasma verapamil concentrations exceeded 400 ng/ml. These results show that plasma verapamil concentrations reliably reflect the electrophysiologic and hemodynamic actions of the drug, and that "therapeutic" drug effects can be achieved at plasma concentrations at which myocardial depressant effects are unlikely.


This article has been cited by other articles:


Home page
Arch Intern MedHome page
J. I. Haft and M. A. Habbab
Treatment of Atrial Arrhythmias: Effectiveness of Verapamil When Preceded by Calcium Infusion
Arch Intern Med, June 1, 1986; 146(6): 1085 - 1089.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
M. H. Hwang, J. Danoviz, I. Pacold, N. Rad, H. S. Loeb, and R. M. Gunnar
Double-blind Crossover Randomized Trial of Intravenously Administered Verapamil: Its Use for Atrial Fibrillation and Flutter Following Open Heart Surgery
Arch Intern Med, March 1, 1984; 144(3): 491 - 494.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
C. Tommaso, T. McDonough, M. Parker, and J. V. Talano
Atrial Fibrillation and Flutter: Immediate Control and Conversion With Intravenously Administered Verapamil
Arch Intern Med, May 1, 1983; 143(5): 877 - 881.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
B. N. Singh
Pharmacological Basis for the Therapeutic Applications of Slow-Channel Blocking Drugs
Angiology, August 1, 1982; 33(8): 492 - 515.
[PDF]


Home page
ANGIOLOGYHome page
J. Kieval and R. J. Myerburg
The Hemodynamic Effects of Calcium Channel Blocking Agents: A Brief Review
Angiology, August 1, 1982; 33(8): 516 - 521.
[PDF]


Home page
ANN INTERN MEDHome page
H. L. WAXMAN, R. J. MYERBURG, R. APPEL, and R. J. SUNG
Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or Flutter: A Double-Blind Randomized Cross-Over Study
Ann Intern Med, January 1, 1981; 94(1): 1 - 6.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
P. H. STONE, E. M. ANTMAN, J. E. MULLER, and E. BRAUNWALD
Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part II: Hemodynamic Effects and Clinical Applications
Ann Intern Med, December 1, 1980; 93(6): 886 - 904.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
R. LAZZARA and B. SCHERLAG
Treatment of Arrhythmias by Blocking Slow Current
Ann Intern Med, December 1, 1980; 93(6): 919 - 921.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
R. J. SUNG, B. ELSER, and R. G. McALLISTER Jr
Intravenous Verapamil for Termination of Re-Entrant Supraventricular Tachycardias: Intracardiac Studies Correlated with Plasma Verapamil Concentrations
Ann Intern Med, November 1, 1980; 93(5): 682 - 689.
[Abstract] [PDF]